Načítá se...
A Randomized, Double-Blind Phase I/IIa Study of Intranasal Glutathione in Parkinson’s Disease
BACKGROUND: Depletion of reduced glutathione is associated with Parkinson’s disease (PD) and glutathione augmentation has been proposed as a disease-modifying strategy. OBJECTIVES: The purpose of this study was to determine the safety and tolerability of intranasal reduced glutathione in individuals...
Uloženo v:
| Vydáno v: | Mov Disord |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609266/ https://ncbi.nlm.nih.gov/pubmed/26230671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26351 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|